Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region
Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) single-dose vials is the bioequivalent to the reference listed drug (RLD) Halaven injection of Eisai, Inc.
The approval is supported by results from the Phase 3 SWOG 1826 trial
Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices
Based in the global marketing function, he will be responsible for strengthening the company's visibility among sponsors, partners and industry stakeholders worldwide
Vijay brings more than 28 years of experience across healthcare, technology, edtech, manufacturing, and global business environments
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
